Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.51
+0.08 (1.01%)
Sep 2, 2026, 10:11 AM EDT - Market open
Aura Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 67.84 | 59.52 | 31.69 | 41.06 | 121.58 | 149.06 |
Short-Term Investments | 256 | 84.73 | 119.4 | 185.09 | 67.23 | - |
Cash & Short-Term Investments | 323.84 | 144.24 | 151.09 | 226.15 | 188.81 | 149.06 |
Cash Growth | 82.64% | -4.54% | -33.19% | 19.78% | 26.66% | 757.03% |
Prepaid Expenses | 0.65 | 1.67 | 1.7 | 1.82 | 2.17 | 2.73 |
Restricted Cash | - | - | - | 0.02 | 0.02 | 0.02 |
Other Current Assets | 2.77 | 3.83 | 7.83 | 3.81 | 5.7 | 1.88 |
Total Current Assets | 329.03 | 149.74 | 160.62 | 231.79 | 196.7 | 153.7 |
Property, Plant & Equipment | 17.19 | 18.45 | 20.59 | 22 | 26.04 | 6.2 |
Other Long-Term Assets | 1.91 | 1.24 | 1.29 | 1.28 | 1.19 | 0.13 |
Total Assets | 348.13 | 169.43 | 182.5 | 255.08 | 223.94 | 160.03 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.25 | 1.55 | 2.3 | 1.79 | 2.92 | 2.4 |
Accrued Expenses | 13.11 | 13.35 | 9.27 | 6.95 | 4.25 | 3.83 |
Current Portion of Leases | 3.29 | 3.24 | 3.15 | 2.69 | 2.96 | 0.62 |
Other Current Liabilities | 0.91 | 0.24 | 0.19 | 0.94 | 0.33 | 0.51 |
Total Current Liabilities | 19.56 | 18.38 | 14.91 | 12.36 | 10.46 | 7.36 |
Long-Term Leases | 13.3 | 14.13 | 15.62 | 16.87 | 17.9 | 0.36 |
Total Liabilities | 32.86 | 32.52 | 30.53 | 29.23 | 28.35 | 7.72 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Additional Paid-In Capital | 914.77 | 617.43 | 525.93 | 512.62 | 406.56 | 304.45 |
Retained Earnings | -559.74 | -480.42 | -374.23 | -287.31 | -210.9 | -152.14 |
Comprehensive Income & Other | -0.67 | -0.1 | 0.26 | 0.54 | -0.07 | - |
Total Common Equity | 315.27 | 136.91 | 151.97 | 225.85 | 195.58 | 152.32 |
Shareholders' Equity | 315.27 | 136.91 | 151.97 | 225.85 | 195.58 | 152.32 |
Total Liabilities & Equity | 348.13 | 169.43 | 182.5 | 255.08 | 223.94 | 160.03 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 16.59 | 17.38 | 18.77 | 19.56 | 20.86 | 0.98 |
Net Cash (Debt) | 307.25 | 126.86 | 132.33 | 206.59 | 167.95 | 148.09 |
Net Cash Growth | 93.00% | -4.13% | -35.95% | 23.01% | 13.41% | 751.42% |
Net Cash Per Share | 4.16 | 2.10 | 2.67 | 5.21 | 5.61 | 28.70 |
Filing Date Shares Outstanding | 103.7 | 64.15 | 50.23 | 49.5 | 37.8 | 29.22 |
Total Common Shares Outstanding | 103.48 | 63.59 | 50 | 49.35 | 37.77 | 29.21 |
Working Capital | 309.47 | 131.36 | 145.71 | 219.44 | 186.25 | 146.35 |
Book Value Per Share | 3.05 | 2.15 | 3.04 | 4.58 | 5.18 | 5.21 |
Tangible Book Value | 315.27 | 136.91 | 151.97 | 225.85 | 195.58 | 152.32 |
Tangible Book Value Per Share | 3.05 | 2.15 | 3.04 | 4.58 | 5.18 | 5.21 |
Machinery | 9.01 | 8.98 | 8.46 | 7.8 | 7.43 | 5.64 |
Construction In Progress | 0.29 | 0.23 | 0.27 | 0.39 | 1.81 | 2.37 |
Leasehold Improvements | 0.47 | 0.47 | 0.47 | - | - | 0.01 |